Macrophages are a key component of the tumor microenvironment (TME). Blocking Clever-1, a molecule expressed in M2-like macrophages, unleashed macrophage and T-cell-mediated antitumor immunity. Myeloid checkpoints including Clever-1 hold promise as alternative or complementary immunotherapy strategies.<i>See related article by Viitala et al., p. 3289</i>.
Gabriele Galliverti, Stephan Wullschleger, Mélanie Tichet, Dhaarini Murugan, Nadine Zangger, Wesley Horton, Alan J. Korman, Lisa M. Coussens, Melody A. Swartz, Douglas Hanahan
Discussion(0)
No comments yet. Be the first to comment.